Professional Documents
Culture Documents
44 Daumit2013
44 Daumit2013
original article
A BS T R AC T
BACKGROUND
From the Welch Center for Prevention, Overweight and obesity are epidemic among persons with serious mental illness,
Epidemiology, and Clinical Research, yet weight-loss trials systematically exclude this vulnerable population. Lifestyle
Johns Hopkins University (G.L.D., N.-Y.W.,
R.M.C., J.C., E.G., L.J.A.), Division of Gen- interventions require adaptation in this group because psychiatric symptoms and
eral Internal Medicine (G.L.D., N.-Y.W., cognitive impairment are highly prevalent. Our objective was to determine the ef-
A.D., G.J.J., A.Y., J.V.G., M.O., J.C., L.M.C., fectiveness of an 18-month tailored behavioral weight-loss intervention in adults
L.J.A.) and Department of Psychiatry
(G.L.D., R.M.C.), Johns Hopkins Univer- with serious mental illness.
sity School of Medicine, Departments of
METHODS
Epidemiology (G.L.D., R.M.C., E.G., L.J.A.),
Health Policy and Management (G.L.D., We recruited overweight or obese adults from 10 community psychiatric rehabilita-
K.D.F.), Mental Health (G.L.D., R.M.C.), tion outpatient programs and randomly assigned them to an intervention or a
and Biostatistics (N.-Y.W.), Johns Hop-
kins Bloomberg School of Public Health, control group. Participants in the intervention group received tailored group and
Department of Veterans Affairs Capitol individual weight-management sessions and group exercise sessions. Weight
Health Care Network (VISN 5) Mental Ill- change was assessed at 6, 12, and 18 months.
ness, Education, and Clinical Research
Center (R.W.G.), and Department of Psy- RESULTS
chiatry, University of Maryland School of
Medicine (R.W.G.), Baltimore; Sheppard
Of 291 participants who underwent randomization, 58.1% had schizophrenia or a
Pratt Health System (F.B.D.), and Depart- schizoaffective disorder, 22.0% had bipolar disorder, and 12.0% had major depres-
ment of Kinesiology, Towson University sion. At baseline, the mean body-mass index (the weight in kilograms divided by
(G.J.J.), Towson; and Social and Scientific
Systems (S.S.C.), Silver Spring — all in
the square of the height in meters) was 36.3, and the mean weight was 102.7 kg
Maryland; Division of Preventive Medi- (225.9 lb). Data on weight at 18 months were obtained from 279 participants.
cine, Department of Family and Preven- Weight loss in the intervention group increased progressively over the 18-month
tive Medicine, University of California,
San Diego, La Jolla (C.A.M.A.); Depart-
study period and differed significantly from the control group at each follow-up
ment of Research and Evaluation, Kaiser visit. At 18 months, the mean between-group difference in weight (change in inter-
Permanente Southern California, Pasadena vention group minus change in control group) was −3.2 kg (−7.0 lb, P = 0.002);
(D.R.Y.); and the National Center for Car-
diovascular Research, Madrid (E.G.). Ad-
37.8% of the participants in the intervention group lost 5% or more of their initial
dress reprint requests to Dr. Daumit at weight, as compared with 22.7% of those in the control group (P = 0.009). There
Johns Hopkins Medical Institutions, were no significant between-group differences in adverse events.
2024 E. Monument St., Baltimore, MD
21287, or at gdaumit@jhmi.edu. CONCLUSIONS
This article was published on March 21,
A behavioral weight-loss intervention significantly reduced weight over a period of
2013, at NEJM.org. 18 months in overweight and obese adults with serious mental illness. Given the
epidemic of obesity and weight-related disease among persons with serious mental
N Engl J Med 2013;368:1594-602.
DOI: 10.1056/NEJMoa1214530
illness, our findings support implementation of targeted behavioral weight-loss
Copyright © 2013 Massachusetts Medical Society. interventions in this high-risk population. (Funded by the National Institute of
Mental Health; ACHIEVE ClinicalTrials.gov number, NCT00902694.)
P
ersons with serious mental illness, ME THODS
such as schizophrenia, bipolar disorder, and
major depression, have mortality rates that STUDY OVERSIGHT
are two to more than three times as high as the Institutional review boards at Johns Hopkins Uni-
rate in the overall population, and the primary versity and Sheppard Pratt Health System and an
cause of death in such persons is cardiovascular independent data and safety monitoring board
disease.1-4 Concomitantly, this vulnerable popula- approved the protocol for the Randomized Trial
tion has an extremely high prevalence of obesity, of Achieving Healthy Lifestyles in Psychiatric Re-
nearly twice that of the overall population.5-9 habilitation (ACHIEVE). All participants provid-
Therefore, it is not surprising that persons with ed written informed consent. The first author
serious mental illness have an increased burden of designed the study, wrote the manuscript, and
weight-related conditions, including heightened vouches for the accuracy of the data and analy-
risk of diabetes mellitus, hypertension, dyslipid- ses. The study was conducted according to the
emia, and certain cancers.10-15 study protocol (available with the full text of this
Obesity is multifactorial in persons with seri- article at NEJM.org). No commercial weight-loss
ous mental illness. Physical inactivity and un- entity was associated with this study.
healthy diets are commonplace.16-18 In addition,
many psychotropic medications, often required for SETTING AND STUDY POPULATION
long-term symptom control, cause weight gain, in We placed the trial in outpatient psychiatric reha-
part through increased appetite and the resultant bilitation programs, settings that provide poten-
high caloric intake.19-22 Hence, lifestyle interven- tially unrealized opportunities to deliver lifestyle
tions to modify diet and activity should have a interventions. These programs serve large num-
central role in stemming the epidemic of obesity bers of persons with serious mental illness and
and obesity-related conditions23-25 in this group. offer vocational and skills training, case man-
Yet persons with serious mental illness, par- agement, and other services. Programs typically
ticularly schizophrenia, often have impairments have commercial kitchens and communal space
in memory and executive function, as well as re- that can be used for multiple functions, includ-
sidual psychiatric symptoms, that impede learn- ing group exercise. Program enrollees often at-
ing and adoption of new behaviors.26 Furthermore, tend these programs multiple times each week,
low socioeconomic status probably contributes which facilitates the delivery of lifestyle interven-
to reduced access to healthy foods and lack of tions that involve frequent contact.
affordable, safe places to exercise.17,27,28 Stigma The study population consisted of overweight
associated with mental illness may also contrib- or obese adults (≥18 years of age) who attended
ute to low levels of participation in mainstream 1 of 10 community psychiatric rehabilitation pro-
leisure-time physical activities.29,30 grams in central Maryland or their affiliated out-
Lifestyle interventions for overweight or obese patient mental health clinics. The eligibility cri-
persons with serious mental illness must address teria were minimal; we aimed to enroll a broad
these special needs. Owing to concerns about population that would be representative of persons
adherence and ability to participate in groups, with serious mental illness attending community
lifestyle-intervention trials in the general popula- mental health programs.39 We excluded persons
tion typically exclude persons with serious men- with a medical contraindication to weight loss, a
tal illness.24,31-36 The few behavioral weight-loss cardiovascular event within the previous 6 months,
trials targeting persons with serious mental ill- an inability to walk, or an active alcohol-use or
ness have had short study periods, small samples, substance-use disorder (see the Supplementary
and other limitations.37,38 The purpose of our Appendix, available at NEJM.org).
trial was to determine the effectiveness of an Participants were enrolled between January
18-month tailored behavioral weight-loss inter- 2009 and February 2011. Study staff recruited
vention in adults with serious mental illness who participants by means of presentations at study
were attending community outpatient psychiatric sites and received referrals from rehabilitation-
rehabilitation programs. program staff.
Individual participants were randomly assigned tion. Ongoing training and quality assurance in-
to the intervention or control group. Randomiza- cluded regular observation of intervention staff.
tion was stratified according to sex and study site;
assignments were generated in blocks of two and CONTROL GROUP
four. Data collectors were unaware of the study Participants in the control group received standard
assignments. nutrition and physical-activity information at base-
Rehabilitation programs routinely provided line. Health classes were offered quarterly, with
breakfast and lunch to all program attendees. To content unrelated to weight (e.g., cancer screening).
facilitate the availability of reduced-calorie food
choices for participants in the intervention group, DATA COLLECTION
we advised kitchen staff on offering healthier Data collectors visited the rehabilitation programs
meals at the programs (see the Supplementary to determine study eligibility, to collect baseline
Appendix). data, and to perform follow-up assessments at
6, 12, and 18 months. Height was measured at
INTERVENTION GROUP study entry. At each visit, weight was measured
The conceptual framework of the intervention with the use of a high-quality, calibrated digital
incorporated social cognitive and behavioral self- scale, with the participant wearing indoor cloth-
management theories and was congruent with ing and no shoes. Measurements of blood pres-
psychiatric rehabilitation principles of skill build- sure, waist circumference, and fasting blood
ing and environmental supports.40-42 The inter- chemical levels were obtained at baseline and at
vention built on lifestyle interventions that stud- 6 and 18 months. Information on sociodemo-
ies have shown to be effective in the general graphic characteristics and medications were ob-
population.32,36 In addition, it was tailored to ad- tained from participant self-reports and program
dress deficits in memory and executive function records; psychiatric diagnoses were abstracted
(e.g., by dividing information into small compo- from program records.
nents and targeting skills repeatedly).43,44
The intervention was composed of three con- STATISTICAL ANALYSIS
tact types: group weight-management sessions, Analyses were conducted according to the inten-
individual weight-management sessions, and group tion-to-treat principle. Primary outcomes were
exercise sessions. The goals for the intervention changes in weight from randomization to 6 months
group included the following: reducing caloric in- and 18 months. Other weight-related outcomes
take by avoiding sugar-sweetened beverages and included percentage of weight change from base-
junk food (e.g., candy and high-fat snacks), eating line, percentage of participants at or below base-
five total servings of fruits and vegetables daily, line weight, percentages of participants who lost
choosing smaller portions and healthy snacks, and at least 5% of their initial weight and those who
participating in moderate-intensity aerobic exercise lost at least 10%, and change from baseline in
(see the Supplementary Appendix). body-mass index (BMI; the weight in kilograms
Group exercise started at a level appropriate for divided by square of height in meters). Weight
sedentary persons, with gradual increases in dura- data obtained within a 45-day window before or
tion and intensity.45 Trained members of the study after the data-collection points and data obtained
staff led all exercise classes for the first 6 months. before a protocol-defined censoring event (e.g.,
Subsequently, a trained member of the rehabilita- pregnancy) were included in the primary analysis,
tion-program staff offered some exercise sessions which was conducted with the use of a likelihood-
using a video specifically prepared for this trial. based mixed-effects model, with weight as a func-
To reinforce the intervention goals, we asked tion of study-group assignment and study visit (at
participants to monitor key behaviors with the baseline and at 6, 12, and 18 months) and with
use of a simplified tracking tool and to meet missing data treated as missing at random. The
with intervention staff to monitor their weight. model was adjusted for study site and sex. An
Session attendance was incentivized with points unstructured covariance structure was used to
that participants traded for small reward items. relate repeated measures, with the use of robust
Standardized procedures and materials pro- standard errors for statistical inferences.
moted fidelity of the study staff to the interven- The same modeling approach was applied to
R E SULT S
144 Were assigned to intervention
147 Were assigned to control group
STUDY PARTICIPANTS group
* Plus–minus values are means ±SD. There were no significant between-group differences in the baseline characteristics,
except for mean number of psychotropic medications (P = 0.006 by the two-sample t-test).
† To convert values for weight to pounds, multiply by 2.2.
‡ The body-mass index is the weight in kilograms divided by the square of the height in meters.
§ Race and ethnic group were self-reported. Other races included Asian and American Indian.
¶ Atypical antipsychotic medication included clozapine, olanzapine, aripiprazole, risperidone, paliperidone, quetiapine,
ziprasidone, and asenapine. However, not all possible atypical antipsychotic medications were represented in the par-
ticipants.
‖ Overall summary scores on the Behavior and Symptom Identification Scale (BASIS-24) range from 0 to 4, with higher
scores indicating greater severity of symptoms.46
** Scores on the Center for Epidemiologic Studies Depression Scale (CES-D) range from 0 to 60, with higher scores indicating
more depressive symptoms; a score of 16 points is considered to be a cutoff point for depression.47
†† Data were missing for 16 participants in the intervention group and 16 in the control group. Total scores on the Repeatable
Battery for the Assessment of Neuropsychological Status (RBANS) range from 40 to 160, with higher scores indicating
better cognitive functioning. Published mean scores are 70 for patients with schizophrenia and 85 for those with bipolar
disorder; a nonpsychiatric sample had a mean score of 95.48
or placing such programs in other mental health ever, the large number of offered contact oppor-
settings would require financial and organiza- tunities allowed for continued exposure to the
tional resources. intervention sessions, even for persons with in-
This trial has several strengths. First, we en- frequent attendance. Thus, the trial reflects ac-
rolled a diverse population of patients with seri- tual attendance patterns of persons with serious
ous mental illnesses from multiple community- mental illness, who often have competing inter-
based programs. We enrolled persons with a current issues.26 Second, the trial was not de-
range of psychiatric diagnoses and did not re- signed or powered to determine the effects of
quire that patients be receiving treatment with a weight reduction on cardiovascular risk factors in
specific psychotropic regimen. In fact, the use of this population. Hence, nonsignificant changes
psychotropic medications that lead to weight in blood pressure and fasting lipid and glucose
gain19-22 was commonplace. A large proportion levels (see the Supplementary Appendix) should
of participants had substantial psychiatric symp- be interpreted cautiously. Third, the trial was not
toms, as evidenced by baseline scores on the designed to influence the prescribing of medica-
Behavior and Symptom Identification Scale,46 tion. In clinical practice, the consideration of
the Center for Epidemiologic Studies Depression psychotropic medications with less obesogenic
Scale,47 and the Repeatable Battery for the As- potential for appropriate patients may help them
sessment of Neuropsychological Status.48 De- reach weight goals. Fourth, our efforts to pro-
spite psychotropic-medication use and ongoing vide healthy meal options were available to all
psychiatric symptoms, participants in the inter- participants in the rehabilitation programs. This
vention group had significant weight loss. Sec- may have influenced weight in the control group.
ond, throughout the trial, we attained high follow- If so, the trial results are conservative.
up rates for outcome data. Very few missing data In conclusion, our results show that over-
and high correlations between weight measures weight and obese adults with serious mental ill-
allowed for robust statistical inferences (see the ness can make substantial lifestyle changes de-
Supplementary Appendix). Third, the interven- spite the myriad challenges they face. Given the
tion was offered over a period of 18 months, in epidemic of obesity and weight-related disease
contrast to the short-term interventions in previ- among persons with serious mental illness, our
ous randomized trials of behavioral weight-loss findings support implementation of targeted
interventions in this population. behavioral weight-loss interventions in this high-
Our trial has limitations. Over the course of risk population.
the study, attendance at the intervention sessions
Supported by the National Institute of Mental Health.
and rehabilitation programs decreased; reasons Disclosure forms provided by the authors are available with
included hospitalizations and social issues. How- the full text of this article at NEJM.org.
REFERENCES
1. Colton CP, Manderscheid RW. Con- 5. Allison DB, Newcomer JW, Dunn AL, 10. Bresee LC, Majumdar SR, Patten SB,
gruencies in increased mortality rates, et al. Obesity among those with mental Johnson JA. Prevalence of cardiovascular
years of potential life lost, and causes of disorders: a National Institute of Mental risk factors and disease in people with
death among public mental health clients Health meeting report. Am J Prev Med schizophrenia: a population-based study.
in eight states. Prev Chronic Dis 2006; 2009;36:341-50. Schizophr Res 2010;117:75-82.
3:A42. 6. Coodin S. Body mass index in persons 11. Carney CP, Jones L, Woolson RF. Med-
2. Daumit GL, Anthony CB, Ford DE, et with schizophrenia. Can J Psychiatry ical comorbidity in women and men with
al. Pattern of mortality in a sample of 2001;46:549-55. schizophrenia: a population-based con-
Maryland residents with severe mental ill- 7. Daumit GL, Clark JM, Steinwachs trolled study. J Gen Intern Med
ness. Psychiatry Res 2010;176:242-5. DM, Graham CM, Lehman A, Ford DE. 2006;21:1133-7.
3. Druss BG, Zhao L, Von Esenwein S, Prevalence and correlates of obesity in a 12. Carney CP, Jones LE. Medical comor-
Morrato EH, Marcus SC. Understanding community sample of individuals with se- bidity in women and men with bipolar
excess mortality in persons with mental vere and persistent mental illness. J Nerv disorders: a population-based controlled
illness: 17-year follow up of a nationally Ment Dis 2003;191:799-805. study. Psychosom Med 2006;68:684-91.
representative US survey. Med Care 2011; 8. Dickerson FB, Brown CH, Kreyenbuhl 13. Himelhoch S, Lehman A, Kreyenbuhl
49:599-604. JA, et al. Obesity among individuals with J, Daumit G, Brown C, Dixon L. Preva-
4. Saha S, Chant D, McGrath J. A system- serious mental illness. Acta Psychiatr lence of chronic obstructive pulmonary
atic review of mortality in schizophrenia: Scand 2006;113:306-13. disease among those with serious mental
is the differential mortality gap worsen- 9. McElroy SL. Correlates of overweight illness. Am J Psychiatry 2004;161:2317-9.
ing over time? Arch Gen Psychiatry 2007; and obesity in 644 patients with bipolar 14. McEvoy JP, Meyer JM, Goff DC, et al.
64:1123-31. disorder. J Clin Psychiatry 2002;63:207-13. Prevalence of the metabolic syndrome in
patients with schizophrenia: baseline re- sation and selection hypotheses. Am J 43. Green MF, Nuechterlein KH. Should
sults from the Clinical Antipsychotic Trials Orthopsychiatry 2005;75:3-18. schizophrenia be treated as a neurocogni-
of Intervention Effectiveness (CATIE) 29. Hinshaw S. The mark of shame: stig- tive disorder? Schizophr Bull 1999;25:
schizophrenia trial and comparison with ma of mental illness and an agenda for 309-19.
national estimates from NHANES III. change. New York: Oxford University 44. Velligan DI, Bow-Thomas CC, Hunt
Schizophr Res 2005;80:19-32. Press, 2007. zinger C, et al. Randomized controlled
15. McGinty EE, Zhang Y, Guallar E, et al. 30. Thornicroft G, Brohan E, Rose D, Sar- trial of the use of compensatory strategies
Cancer incidence in a sample of Maryland torius N, Leese M. Global pattern of expe- to enhance adaptive functioning in outpa-
residents with serious mental illness. Psy- rienced and anticipated discrimination tients with schizophrenia. Am J Psychiatry
chiatr Serv 2012;63:714-7. against people with schizophrenia: a 2000;157:1317-23.
16. Daumit GL, Goldberg RW, Anthony C, cross-sectional survey. Lancet 2009;373: 45. American Heart Association, National
et al. Physical activity patterns in adults 408-15. Heart, Lung, and Blood Institute. Exercise
with severe mental illness. J Nerv Ment 31. Appel LJ, Clark JM, Yeh HC, et al. and your heart: a guide to physical activity.
Dis 2005;193:641-6. Comparative effectiveness of weight-loss Bethesda, MD: National Institutes of
17. Dipasquale S, Pariante CM, Dazzan P, interventions in clinical practice. N Engl J Health, 1993.
Aguglia E, McGuire P, Mondelli V. The di- Med 2011;365:1959-68. 46. Eisen SV, Normand SL, Belanger AJ,
etary patterns of patients with schizo- 32. Elmer PJ, Obarzanek E, Vollmer WM, Spiro A III, Esch D. The Revised Behavior
phrenia: a systematic review. J Psychiatr et al. Effects of comprehensive lifestyle and Symptom Identification Scale (BASIS-
Res 2013;47:197-207. modification on diet, weight, physical R): reliability and validity. Med Care 2004;
18. Jerome GJ, Young DR, Dalcin A, et al. fitness, and blood pressure control: 42:1230-41.
Physical activity levels of persons with 18-month results of a randomized trial. 47. Weissman MM, Sholomskas D, Pot-
mental illness attending psychiatric reha- Ann Intern Med 2006;144:485-95. tenger M, Prusoff BA, Locke BZ. Assess-
bilitation programs. Schizophr Res 2009; 33. Hollis JF, Gullion CM, Stevens VJ, et al. ing depressive symptoms in five psychiat-
108:252-7. Weight loss during the intensive interven- ric populations: a validation study. Am J
19. Depression Guideline Panel. Depres- tion phase of the Weight Loss Maintenance Epidemiol 1977;106:203-14.
sion in primary care. Vol. 2. Rockville, MD: trial. Am J Prev Med 2008;35:118-26. 48. Dickerson F, Boronow JJ, Stallings C,
Agency for Health Care Policy and Re- 34. Sacks FM, Bray GA, Carey VJ, et al. Origoni AE, Cole SK, Yolken RH. Cogni-
search, 1993. (AHCPR publication no. 93- Comparison of weight-loss diets with dif- tive functioning in schizophrenia and bi-
0551.) ferent compositions of fat, protein, and car- polar disorder: comparison of perfor-
20. Allison DB, Mentore JL, Heo M, et al. bohydrates. N Engl J Med 2009;360:859-73. mance on the Repeatable Battery for the
Antipsychotic-induced weight gain: a 35. Wadden TA, Volger S, Sarwer DB, et Assessment of Neuropsychological Status.
comprehensive research synthesis. Am J al. A two-year randomized trial of obesity Psychiatry Res 2004;129:45-53.
Psychiatry 1999;156:1686-96. treatment in primary care practice. N Engl 49. Foster GD, Wyatt HR, Hill JO, et al.
21. Lieberman JA, Stroup TS, McEvoy JP, J Med 2011;365:1969-79. Weight and metabolic outcomes after
et al. Effectiveness of antipsychotic drugs 36. Whelton PK, Appel LJ, Espeland MA, 2 years on a low-carbohydrate versus low-
in patients with chronic schizophrenia. et al. Sodium reduction and weight loss in fat diet: a randomized trial. Ann Intern
N Engl J Med 2005;353:1209-23. [Erratum, the treatment of hypertension in older Med 2010;153:147-57.
N Engl J Med 2010;363:1092-3.] persons: a randomized controlled Trial of 50. Bartels SJ, Desilets R. Health promo-
22. Macritchie KAN, Geddes JR, Scott J, Nonpharmacologic Interventions in the tion programs for people with serious men-
Haslam DRS, Goodwin GM. Valproic acid, Elderly (TONE). JAMA 1998;279:839-46. tal illness (prepared by the Dartmouth
valproate and divalproex in the main 37. Cabassa LJ, Ezell JM, Lewis-Fernandez Health Promotions Research Team). Wash-
tenance treatment of bipolar disorder. R. Lifestyle interventions for adults with ington, DC: SAMHSA-HRSA Center for In-
Cochrane Database Syst Rev 2001;3: serious mental illness: a systematic litera- tegrated Health Solutions, January 2012.
CD003196. ture review. Psychiatr Serv 2010;61:774-82. 51. McKibbin CL, Patterson TL, Norman
23. Stamler R, Stamler J, Gosch FC, et al. 38. Faulkner G, Cohn T, Remington G. G, et al. A lifestyle intervention for older
Primary prevention of hypertension by Interventions to reduce weight gain in schizophrenia patients with diabetes mel-
nutritional-hygienic means: final report schizophrenia. Cochrane Database Syst litus: a randomized controlled trial.
of a randomized, controlled trial. JAMA Rev 2007;1:CD005148. Schizophr Res 2006;86:36-44.
1989;262:1801-7. [Erratum, JAMA 1989; 39. Casagrande SS, Jerome GJ, Dalcin AT, 52. Verhaeghe N, De Maeseneer J, Maes L,
262:3132.] et al. Randomized Trial of Achieving Van Heeringen C, Annemans L. Effective-
24. Stevens VJ, Obarzanek E, Cook NR, et Healthy Lifestyles in Psychiatric Rehabili- ness and cost-effectiveness of lifestyle in-
al. Long-term weight loss and changes in tation: the ACHIEVE trial. BMC Psychia- terventions on physical activity and eating
blood pressure: results of the Trials of Hy- try 2010;10:108. habits in persons with severe mental dis-
pertension Prevention, phase II. Ann In- 40. Bandura A, ed. Social foundations of orders: a systematic review. Int J Behav
tern Med 2001;134:1-11. thought and action: a social cognitive Nutr Phys Act 2011;8:28.
25. Tuomilehto J, Lindström J, Eriksson theory. Englewood Cliffs, NJ: Prentice- 53. Wu MK, Wang CK, Bai YM, Huang CY,
JG, et al. Prevention of type 2 diabetes Hall, 1986. Lee SD. Outcomes of obese, clozapine-
mellitus by changes in lifestyle among 41. Heinssen RK. The cognitive exoskel- treated inpatients with schizophrenia
subjects with impaired glucose tolerance. eton: environmental interventions in cog- placed on a six-month diet and physical
N Engl J Med 2001;344:1343-50. nitive rehabilitation. In: Corrigan PW, activity program. Psychiatr Serv 2007;58:
26. Mueser KT, McGurk SR. Schizophre- Yudofsky SC, eds. Cognitive rehabilitation 544-50.
nia. Lancet 2004;363:2063-72. for neuropsychiatric disorders. Washing- 54. Wu RR, Zhao JP, Jin H, et al. Lifestyle
27. Agerbo E, Byrne M, Eaton WW, ton, DC: American Psychiatric Press, 1996: intervention and metformin for treatment
Mortensen PB. Marital and labor market 395-423. of antipsychotic-induced weight gain: a
status in the long run in schizophrenia. 42. Mueser KT, Corrigan PW, Hilton DW, randomized controlled trial. JAMA 2008;
Arch Gen Psychiatry 2004;61:28-33. et al. Illness management and recovery: a 299:185-93.
28. Hudson CG. Socioeconomic status review of the research. Psychiatr Serv Copyright © 2013 Massachusetts Medical Society.
and mental illness: tests of the social cau- 2002;53:1272-84.